{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,4,5]],"date-time":"2024-04-05T00:49:40Z","timestamp":1712278180270},"reference-count":20,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,4,4]]},"DOI":"10.7759\/cureus.57618","type":"journal-article","created":{"date-parts":[[2024,4,4]],"date-time":"2024-04-04T23:29:30Z","timestamp":1712273370000},"source":"Crossref","is-referenced-by-count":0,"title":["Toxic Epidermal Necrolysis Secondary to Iodine Versus Methimazole in a Pediatric Patient With Complex Autoimmune Disease"],"prefix":"10.7759","author":[{"given":"Katlyn M","family":"Smaha","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John D","family":"Prosser","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jacqueline T","family":"Chan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoto.2021.2715","article-title":"Management of Pediatric Graves Disease: A Review","volume":"147","author":"Quintanilla-Dieck L","year":"2021","unstructured":"Quintanilla-Dieck L, Khalatbari HK, Dinauer CA, et al.. Management of Pediatric Graves Disease: A Review. JAMA Otolaryngol Head Neck Surg. 2021, 147:1110-8. 10.1001\/jamaoto.2021.2715","journal-title":"JAMA Otolaryngol Head Neck Surg"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.21037\/gs.2017.05.09","article-title":"Preoperative management in patients with Graves' disease","volume":"6","author":"Piantanida E","year":"2017","unstructured":"Piantanida E. Preoperative management in patients with Graves' disease. Gland Surg. 2017, 6:476-81. 10.21037\/gs.2017.05.09","journal-title":"Gland Surg"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpedsurg.2016.03.009","article-title":"Thyroidectomy for Graves' disease in children: Indications and complications","volume":"51","author":"Elfenbein DM","year":"2016","unstructured":"Elfenbein DM, Katz M, Schneider DF, Chen H, Sippel RS. Thyroidectomy for Graves' disease in children: Indications and complications. J Pediatr Surg. 2016, 51:1680-3. 10.1016\/j.jpedsurg.2016.03.009","journal-title":"J Pediatr Surg"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1089\/thy.2016.0229","article-title":"2016 American Thyroid Association Guidelines for Diagnosis and Management of Hyperthyroidism and Other Causes of Thyrotoxicosis","volume":"26","author":"Ross DS","year":"2016","unstructured":"Ross DS, Burch HB, Cooper DS, et al.. 2016 American Thyroid Association Guidelines for Diagnosis and Management of Hyperthyroidism and Other Causes of Thyrotoxicosis. Thyroid. 2016, 26:1343-421. 10.1089\/thy.2016.0229","journal-title":"Thyroid"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1007\/s12016-017-8654-z","article-title":"Current Perspectives on Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis","volume":"54","author":"Lerch M","year":"2018","unstructured":"Lerch M, Mainetti C, Terziroli Beretta-Piccoli B, Harr T. Current Perspectives on Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis. Clin Rev Allergy Immunol. 2018, 54:147-76. 10.1007\/s12016-017-8654-z","journal-title":"Clin Rev Allergy Immunol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1155\/2010\/176970","article-title":"Adverse events associated with methimazole therapy of graves' disease in children","volume":"2010","author":"Rivkees SA","year":"2010","unstructured":"Rivkees SA, Stephenson K, Dinauer C. Adverse events associated with methimazole therapy of graves' disease in children. Int J Pediatr Endocrinol. 2010, 2010:176970. 10.1155\/2010\/176970","journal-title":"Int J Pediatr Endocrinol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1754.2006.00901.x","article-title":"Methimazole-induced toxic epidermal necrolysis in a 12-year-old girl","volume":"42","author":"Ziora K","year":"2006","unstructured":"Ziora K, Oswiecimska J, Broll-Waska K, et al.. Methimazole-induced toxic epidermal necrolysis in a 12-year-old girl. J Paediatr Child Health. 2006, 42:472-3. 10.1111\/j.1440-1754.2006.00901.x","journal-title":"J Paediatr Child Health"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.23750\/abm.v90i3-S.8165","article-title":"Clinical features, outcomes and treatment in children with drug induced Stevens-Johnson syndrome and toxic epidermal necrolysis","volume":"90","author":"Liotti L","year":"2019","unstructured":"Liotti L, Caimmi S, Bottau P, et al.. Clinical features, outcomes and treatment in children with drug induced Stevens-Johnson syndrome and toxic epidermal necrolysis. Acta Biomed. 2019, 90:52-60. 10.23750\/abm.v90i3-S.8165","journal-title":"Acta Biomed"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4471-6729-7_24","article-title":"Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis","author":"Klimas N","year":"2015","unstructured":"Klimas N, Quintanilla-Dieck J, Vandergriff T. Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis. Cutaneous Drug Eruptions. 2015, 259-69. 10.1007\/978-1-4471-6729-7_24","journal-title":"Cutaneous Drug Eruptions"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2004.07.047","article-title":"Toxic epidermal necrolysis: effector cells are drug-specific cytotoxic T cells","volume":"114","author":"Nassif A","year":"2004","unstructured":"Nassif A, Bensussan A, Boumsell L, et al.. Toxic epidermal necrolysis: effector cells are drug-specific cytotoxic T cells. J Allergy Clin Immunol. 2004, 114:1209-15. 10.1016\/j.jaci.2004.07.047","journal-title":"J Allergy Clin Immunol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1586\/eci.11.66","article-title":"The current understanding of Stevens-Johnson syndrome and toxic epidermal necrolysis","volume":"7","author":"Mockenhaupt M","year":"2011","unstructured":"Mockenhaupt M. The current understanding of Stevens-Johnson syndrome and toxic epidermal necrolysis. Expert Rev Clin Immunol. 2011, 7:803-13; quiz 814-5. 10.1586\/eci.11.66","journal-title":"Expert Rev Clin Immunol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.2009.252","article-title":"ALDEN, an algorithm for assessment of drug causality in Stevens-Johnson Syndrome and toxic epidermal necrolysis: comparison with case-control analysis","volume":"88","author":"Sassolas B","year":"2010","unstructured":"Sassolas B, Haddad C, Mockenhaupt M, et al.. ALDEN, an algorithm for assessment of drug causality in Stevens-Johnson Syndrome and toxic epidermal necrolysis: comparison with case-control analysis. Clin Pharmacol Ther. 2010, 88:60-8. 10.1038\/clpt.2009.252","journal-title":"Clin Pharmacol Ther"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1038\/sj.jid.5701033","article-title":"Stevens-Johnson syndrome and toxic epidermal necrolysis: assessment of medication risks with emphasis on recently marketed drugs. The EuroSCAR-study","volume":"128","author":"Mockenhaupt M","year":"2008","unstructured":"Mockenhaupt M, Viboud C, Dunant A, et al.. Stevens-Johnson syndrome and toxic epidermal necrolysis: assessment of medication risks with emphasis on recently marketed drugs. The EuroSCAR-study. J Invest Dermatol. 2008, 128:35-44. 10.1038\/sj.jid.5701033","journal-title":"J Invest Dermatol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1111\/ced.13991","article-title":"Contrast media and cutaneous reactions. Part 2: Delayed hypersensitivity reactions to iodinated contrast media","volume":"44","author":"Tasker F","year":"2019","unstructured":"Tasker F, Fleming H, McNeill G, Creamer D, Walsh S. Contrast media and cutaneous reactions. Part 2: Delayed hypersensitivity reactions to iodinated contrast media. Clin Exp Dermatol. 2019, 44:844-60. 10.1111\/ced.13991","journal-title":"Clin Exp Dermatol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1007\/s12020-017-1461-8","article-title":"Lugol's solution and other iodide preparations: perspectives and research directions in Graves' disease","volume":"58","author":"Calissendorff J","year":"2017","unstructured":"Calissendorff J, Falhammar H. Lugol's solution and other iodide preparations: perspectives and research directions in Graves' disease. Endocrine. 2017, 58:467-73. 10.1007\/s12020-017-1461-8","journal-title":"Endocrine"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1530\/EC-17-0025","article-title":"Rescue pre-operative treatment with Lugol's solution in uncontrolled Graves' disease","volume":"6","author":"Calissendorff J","year":"2017","unstructured":"Calissendorff J, Falhammar H. Rescue pre-operative treatment with Lugol's solution in uncontrolled Graves' disease. Endocr Connect. 2017, 6:200-5. 10.1530\/EC-17-0025","journal-title":"Endocr Connect"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/j.clindermatol.2020.06.016","article-title":"Diagnosis and management of Stevens-Johnson syndrome\/toxic epidermal necrolysis","volume":"38","author":"Noe MH","year":"2020","unstructured":"Noe MH, Micheletti RG. Diagnosis and management of Stevens-Johnson syndrome\/toxic epidermal necrolysis. Clin Dermatol. 2020, 38:607-12. 10.1016\/j.clindermatol.2020.06.016","journal-title":"Clin Dermatol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.2165\/11593240-000000000-00000","article-title":"Incidence of toxic epidermal necrolysis and Stevens-Johnson Syndrome in an HIV cohort: an observational, retrospective case series study","volume":"13","author":"Mittmann N","year":"2012","unstructured":"Mittmann N, Knowles SR, Koo M, Shear NH, Rachlis A, Rourke SB. Incidence of toxic epidermal necrolysis and Stevens-Johnson Syndrome in an HIV cohort: an observational, retrospective case series study. Am J Clin Dermatol. 2012, 13:49-54. 10.2165\/11593240-000000000-00000","journal-title":"Am J Clin Dermatol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1007\/BF03345295","article-title":"Fatal toxic epidermal necrolysis in autoimmune polyglandular syndrome type I","volume":"27","author":"Porzionato A","year":"2004","unstructured":"Porzionato A, Zancaner S, Betterle C, Ferrara SD. Fatal toxic epidermal necrolysis in autoimmune polyglandular syndrome type I. J Endocrinol Invest. 2004, 27:475-9. 10.1007\/BF03345295","journal-title":"J Endocrinol Invest"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.12688\/f1000research.24748.1","article-title":"Recent advances in managing and understanding Stevens-Johnson syndrome and toxic epidermal necrolysis","volume":"9","author":"Hasegawa A","year":"2020","unstructured":"Hasegawa A, Abe R. Recent advances in managing and understanding Stevens-Johnson syndrome and toxic epidermal necrolysis. F1000Res. 2020, 9:10.12688\/f1000research.24748.1","journal-title":"F1000Res"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/240082-toxic-epidermal-necrolysis-secondary-to-iodine-versus-methimazole-in-a-pediatric-patient-with-complex-autoimmune-disease","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,4]],"date-time":"2024-04-04T23:29:34Z","timestamp":1712273374000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/240082-toxic-epidermal-necrolysis-secondary-to-iodine-versus-methimazole-in-a-pediatric-patient-with-complex-autoimmune-disease"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,4]]},"references-count":20,"URL":"https:\/\/doi.org\/10.7759\/cureus.57618","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,4,4]]}}}